| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChiefDERIV | Jun 11 | D | 41,250 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChiefDERIV | Jun 11 | D | 25,000 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChiefDERIV | Jun 11 | D | 80,000 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChiefDERIV | Jun 11 | D | 18,920 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChiefDERIV | Jun 11 | D | 20,000 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChiefDERIV | Jun 11 | D | 31,000 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChiefDERIV | Jun 11 | D | 60,000 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChiefDERIV | Jun 11 | D | 27,900 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChiefDERIV | Jun 11 | D | 52,600 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChiefDERIV | Jun 11 | D | 53,500 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChief | Jun 11 | D | 229,918 | $0.00 | — |
| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChiefDERIV | May 27 | M | 33,800 | $0.00 | —? |
| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChief | May 27 | S | 33,800 | $26.78 | $905K |
| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChief | May 27 | M | 33,800 | $7.07 | $239K |
| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChiefDERIV | May 22 | M | 3,125 | $0.00 | —? |
| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChief | May 26 | S | 1,966 | $26.78 | $53K |
| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChief | May 22 | M | 3,125 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChiefDERIV | May 21 | M | 3,750 | $0.00 | —? |
| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChief | May 22 | S | 2,358 | $26.78 | $63K |
| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChief | May 21 | M | 3,750 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChiefDERIV | May 17 | M | 1,774 | $0.00 | —? |
| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChief | May 18 | S | 1,108 | $26.76 | $30K |
| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChief | May 17 | M | 1,774 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChiefDERIV | Feb 22 | M | 3,125 | $0.00 | —? |
| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChiefDERIV | Feb 21 | M | 3,750 | $0.00 | —? |
| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChief | Feb 23 | S | 4,347 | $15.57 | $68K |
| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChief | Feb 22 | M | 3,125 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChief | Feb 21 | M | 3,750 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChiefDERIV | Feb 17 | M | 1,774 | $0.00 | —? |
| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChief | Feb 18 | S | 1,109 | $15.00 | $17K |
| KalVista Pharmaceuticals, Inc. | KALV | Christopher YeaChief | Feb 17 | M | 1,774 | — | — |